The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: An Italian multicentric study (SOLISM-IMI)

Journal of Nuclear Medicine

Volumn 47, Issue 2, 2006, Pages 234-241

  Rossi, Carlo Riccardo ^a   De Salvo, Gian Luca ^b   Trifirò, Giuseppe ^c   Mocellin, Simone ^a   Landi, Giorgio ^d   Macripò, Giuseppe ^e   Carcoforo, Paolo ^f   Ricotti, Giuseppe ^g   Giudice, Giuseppe ^h   Picciotto, Franco ⁱ   Donner, Davide ^j   Di Filippo, Franco ^k   Montesco, Maria Cristina ^a   Casara, Dario ^l   Schiavon, Mauro ^m   Foletto, Mirto ^a   Baldini, Federica ^c   Testori, Alessandro ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d BUFALINI HOSPITAL   (Italy)

^e Ospedale San Lazzaro   (Italy)

^f UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^g Ospedale Sestilli   (Italy)

^h UNIVERSITY OF BARI   (Italy)

ⁱ CANDIOLO CANCER INSTITUTE   (Italy)

^j SANTA CHIARA HOSPITAL   (Italy)

^k REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^l UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^m UNIVERSITY HOSPITAL OF UDINE   (Italy)

more..

Author keywords

Cutaneous melanoma; Lymphoscintigraphy; Quality control program; Sentinel node biopsy

Indexed keywords

ALBUMIN; EOSIN; HEMATOXYLIN; PROTEIN ANTIBODY; PROTEIN S 100; TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL STUDY; COLLOID; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MELANOMA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; SENTINEL LYMPH NODE BIOPSY; SKIN SCAR; SKIN ULCER; CLINICAL TRIAL; ITALY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SKIN TUMOR; STATISTICS; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; ITALY; MALE; MELANOMA; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 33845733555     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
2. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004;54:131-149.
3. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351:998-1012.
4. McMasters KM, Wong SL, Edwards MJ, et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery. 2001;130:151-156.
5. Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol. 2004;11:247-258.
6. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197-1202.
7. Mariani G, Erba P, Manca G, et al. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. J Surg Oncol. 2004;85:141-151.
8. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
9. Thompson JF, Stretch JR, Uren RF, et al. Sentinel node biopsy for melanoma: where have we been and where are we going? Ann Surg Oncol. 2004;11(suppl):147S-151S.
10. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003;44:570-582.
11. Bongers V, Borel Rinkes IH, Barneveld PC, et al. Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a European survey. Eur J Nucl Med. 1999;26:84-90.
12. Mudun A, Murray DR, Herda SC, et al. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology. 1996;199:171-175.
13. Kapteijn BA, Nieweg OE, Valdes Olmos RA, et al. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med. 1996;37:972-975.
14. Ross G, Shoaib T, Scott J, et al. The learning curve for sentinel node biopsy in malignant melanoma. Br J Plast Surg. 2002;55:298-301.
15. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253-2260.
16. Jacobs IA, Chevinsky AH, Swayne LC, et al. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: reliability of the procedure and analysis of failures after long-term follow-up. J Surg Oncol. 2001;77:157-164.
17. Jansen L, Nieweg OE, Kapteijn AE, et al. Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol. 2000;7:624-630.
18. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg. 2001;233:250-258.
19. Harlow SP, Krag DN, Ashikaga T, et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res. 2001;11:45-55.
20. Cascinelli N. WHO Melanoma Programme: results of the sentinel node study. Proceedings of Sentinel Node 2000, 2nd International Sentinel Node Congress. Santa Monica, CA, December 1-4, 2000.
21. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol. 2003;10:681-688.
22. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer. 2001;92:535-541.
23. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol. 2003;200:314-319.
24. Kuo CT, Hoon DS, Takeuchi H, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol. 2003;21:3566-3572.
25. Leak LV. Lymphatic vessels. In: Johannessen JV, ed. Cardiovascular System, Lymphoreticular and Hematopoietic System. New York, NY: McGraw-Hill; 1980:159-183.
26. Ryan TS. The lymphatics of the skin. In: Jarrett A, ed. The Physiology and Pathophysiology of the Skin. London, U.K.: Academic Press; 1978:1755-1780.
27. Valdes Olmos RA, Nieweg OE. Reproducibility of cutaneous lymphoscintigraphy: same or different lymphatic routes and sentinel nodes after reinjection? J Nucl Med. 2001;42:430-431.